$KIN Kindred Biosciences Initiates Pivotal Efficacy Study of Tirnovetmab (Interleukin-31) Monoclonal Antibody for Canine Atopic Dermatitis
December 22, 2020
SAN FRANCISCO , Dec. 22, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ:...
Kindred Biosciences Announces Positive Results from Pilot Field Effectiveness Study for Anti-TNFa Antibody for Canine Inflammatory Bowel Disease
December 21, 2020
SAN FRANCISCO , Dec. 21, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ:...
Kindred Biosciences Announces Agreement Granting Elanco Exclusive Global Rights for its Parvovirus Monoclonal Antibody
December 11, 2020
SAN FRANCISCO , Dec. 11, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ:...
Kindred Biosciences to Present at Guggenheim Animal Health Summit
December 2, 2020
SAN FRANCISCO , Dec. 2, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ:...
Kindred Biosciences to Participate in Stifel Virtual Healthcare Conference and A.G.P. Virtual Healthcare Symposium
November 11, 2020
SAN FRANCISCO , Nov. 11, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ:...
Kindred Biosciences Announces Third Quarter 2020 Financial Results
November 9, 2020
SAN FRANCISCO , Nov. 9, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K...
Kindred Biosciences to Announce Third Quarter 2020 Financial Results
October 28, 2020
Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time/1:30 p.m. P...
Kindred Biosciences Announces Expansion of Manufacturing Agreement with Vaxart for COVID-19 and Other Vaccine Candidates
October 7, 2020
SAN FRANCISCO , Oct. 7, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K...
Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody
September 16, 2020
- Study demonstrated 100% efficacy in prevention of parvovirus infection in proph...
Kindred Biosciences to Participate in H.C. Wainwright Global Investment Conference, Cantor Global Healthcare Conference and Lake Street Best Ideas Growth Conference
September 9, 2020
SAN FRANCISCO , Sept. 9, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ...
Kindred Biosciences Announces Second Quarter 2020 Financial Results
August 5, 2020
SAN FRANCISCO , Aug. 5, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ...
Kindred Biosciences to Announce Second Quarter 2020 Financial Results
July 23, 2020
Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time/1:30 p.m. P...
Kindred Biosciences Announces Plan to Strengthen its Strategic Position
June 8, 2020
SAN FRANCISCO , June 8, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K...
Kindred Biosciences Announces COVID-19 Vaccine Manufacturing Agreement with Vaxart
May 20, 2020
SAN FRANCISCO , May 20, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K...
Kindred Biosciences to Present at Stifel 2020 Virtual Jaws & Paws Conference
May 13, 2020
SAN FRANCISCO , May 13, 2020 /PRNewswire/ -- Kindred Biosciences , Inc. (NASDAQ: ...
Kindred Biosciences Announces First Quarter 2020 Financial Results
May 7, 2020
SAN FRANCISCO , May 7, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K...
Kindred Biosciences to Announce First Quarter 2020 Financial Results
April 23, 2020
Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time/1:30 p.m. P...
Kindred Biosciences Announces Completion of Mirataz® (mirtazapine transdermal ointment) Transaction
April 15, 2020
SAN FRANCISCO , April 15, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ:...
Kindred Biosciences Announces Positive Results from Pilot Field Efficacy Study of its IL-4/IL-13 SINK Molecule Being Developed for the Treatment of Atopic Dermatitis in Dogs
March 24, 2020
SAN FRANCISCO , March 24, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ...
Kindred Biosciences Announces Mirataz® (mirtazapine transdermal ointment) Transaction and Reports Fourth Quarter and Full Year 2019 Financial Results
March 16, 2020
SAN FRANCISCO , March 16, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ...
Kindred Biosciences to Announce Fourth Quarter and Year-End 2019 Financial Results
March 3, 2020
Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time/1:30 p.m. P...
Kindred Biosciences to Present at Bank of America Merrill Lynch Animal Health Summit
February 18, 2020
SAN FRANCISCO , Feb. 18, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ...
Kindred Biosciences Announces Half-Life Extension Technology for Canine Antibodies
January 8, 2020
- Positive results from canine pharmacokinetic study demonstrate up to three-fold...
